MedTrace Logo

Women's Advanced Risk-assessment in Manitoba

NCT03938155 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2021-01-28

No results posted yet for this study

Summary

The main objective of this study is to test the ability of novel cardiovascular disease (CVD) prognostic tools to identify women at risk for future CVD. We plan to establish a cardiovascular health screening program at the St. Boniface Hospital and to test the efficacy of these tests for predicting adverse cardiovascular outcomes amongst a cohort of 1000 Manitoban women aged 55 years and older in the 5-year period after screening.

A second purpose of this project is to identify novel CVD biomarkers that may indicate a person is at risk for cardiovascular disease. Therefore, we plan to ask participants for permission to collect and store a sample of both their blood and stool for future research.

Conditions

  • Cardiovascular Disease (CVD)
  • Cardiovascular Risk Factor
  • Vascular Stiffness

Sponsors & Collaborators

  • St. Boniface Hospital

    lead OTHER

Eligibility

Min Age
55 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-01
Primary Completion
2021-10-01
Completion
2026-10-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03938155 on ClinicalTrials.gov